Keywords: dainippon, sumitomo, discontinues, ac-3933, development, japanese, drugmaker

Dainippon Sumitomo discontinues AC-3933 development

Article | 17 April 2009

Japanese drugmaker Dainippon Sumitomo Pharma has announced the discontinuation of clinical development in Japan and abroad of its investigational compound ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Dainippon Sumitomo Pharma

Go to company listing